All studied nutraceuticals succeeded to improve dyslipidemia, fatty liver, plasma non-HDL-C, TC/HDL-C, oxidative stress, IR, hs-CRP, adiponectin and glucose and liver and kidney function with variable degrees in metabolic syndrome rat model. Here, ADIPOQ is linked to fatty liver disease.